Company: TAK
Filing Date: 2025-07-30
Form Type: 6-K
Source: 0001395064-25-000120
Chunk: 19

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-07-30
Form: 6-K
Chunk 19
---
33.2 billion ( JPY -123.5 billion ). The decrease was mainly due to a decrease in cash outflow used in Acquisition of Intangible Assets, further driven by an increase in Proceeds from Sales of Business, Net of Cash and Cash Equivalents Divested.

#### Net Cash used in Financing Activiti

#### es
Net Cash used in Financing Activities was JPY 214.9 billion ( JPY +531.3 billion) . The increase was mainly driven by lower net cash inflows from the issuance and repayments of bonds and long-term loans as well as increased treasury share acquisitions.

<div align='center'>11</div>

Takeda Pharmaceutical Company Limited (4502)

Earnings Report ( Kessan Tanshin ) for the Three-month

Period Ended June 30, 2025 (Consolidated)

(3) Outlook for the Fiscal Year Ending March 31, 2026

The full year consolidated forecast for the fiscal year ending March 31, 2026 (FY2025) has not been revised from the forecast announced at the FY2024 financial results announcement on May 8, 2025.

### Consolidated Forecast for the Fiscal Year Ending

#### March 31, 2026
(

#### FY2025
#### )

|                                         |     |                |         |     |          |         |     |            |       |     |          |       | Billion JPY or percentage |
|                                         |     | FY2024         
 Actual Results |         |     | FY2025   
 Forecast |         |     | JPY Change |       |     | % Change |       |                           |
| Revenue                                 |     |                | 4,581.6 |     |          | 4,530.0 |     |            | -51.6 |     |          |  -1.1 | %                         |
| Operating profit                        |     |                |   342.6 |     |          |   475.0 |     |            | 132.4 |     |          |  38.7 | %                         |
| Profit before tax                       |     |                |   175.1 |     |          |   307.0 |     |            | 131.9 |     |          |  75.3 | %                         |
| Net profit for the year                 
 (attributable to owners of the Company) |     |                |   107.9 |     |          |